BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34383440)

  • 1. Human Papillomavirus: Screening, Testing, and Prevention.
    Quinlan JD
    Am Fam Physician; 2021 Aug; 104(2):152-159. PubMed ID: 34383440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.
    Wolf J; Kist LF; Pereira SB; Quessada MA; Petek H; Pille A; Maccari JG; Mutlaq MP; Nasi LA
    Rev Med Virol; 2024 May; 34(3):e2537. PubMed ID: 38666757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting to know human papillomavirus (HPV) and the HPV vaccines.
    Smith GD; Travis L
    J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus disease and vaccines.
    Hutchinson DJ; Klein KC
    Am J Health Syst Pharm; 2008 Nov; 65(22):2105-12. PubMed ID: 18997137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening the case for gender-neutral and the nonavalent HPV vaccine.
    Hintze JM; O'Neill JP
    Eur Arch Otorhinolaryngol; 2018 Apr; 275(4):857-865. PubMed ID: 29327306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus Vaccination Coverage in Children Ages 9-17 Years: United States, 2022.
    Villarroel MA; Galinsky AM; Lu PJ; Pingali C
    NCHS Data Brief; 2024 Feb; (495):1-8. PubMed ID: 38358336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV Vaccine in Adolescents.
    Braverman PK
    Pediatr Ann; 2019 Feb; 48(2):e71-e77. PubMed ID: 30747983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
    Harder T; Wichmann O; Klug SJ; van der Sande MAB; Wiese-Posselt M
    BMC Med; 2018 Jul; 16(1):110. PubMed ID: 30016957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human papillomavirus infection and vaccination].
    He ZH; Kou ZQ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):106-112. PubMed ID: 29334719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genitoanal human papillomavirus infection and associated neoplasias.
    Gross G
    Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expanded Impact of Human Papillomavirus Vaccine.
    Pahud BA; Ault KA
    Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
    Guo T; Eisele DW; Fakhry C
    Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pap Testing in the USA and Potential Association with HPV Vaccination: a Cross-sectional Analysis of the BRFSS Data (2007-2016).
    Zhang D; Sun X
    J Gen Intern Med; 2019 Jan; 34(1):17-19. PubMed ID: 30206792
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.
    Chatterjee A
    Expert Rev Vaccines; 2014 Nov; 13(11):1279-90. PubMed ID: 25256262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental vaccines for sexually transmitted infections].
    Jovanović M; Karadaglić D; Golusin Z; Brkić S; Poljacki M
    Med Pregl; 2009; 62(1-2):42-8. PubMed ID: 19514600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.